Supernus Pharmaceuticals (SUPN) EV to CFO (2015 - 2026)
Supernus Pharmaceuticals' EV to CFO was 117.18 in Q2 2026, compared with 6.66 a year earlier and up 273.0% from the prior quarter.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) EV to CFO (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, Supernus Pharmaceuticals' EV to CFO was 68.26 through Jun 30, 2026; for FY2025, it was 53.81, up 492.4% from FY2024.
- In earlier years, EV to CFO was 9.08 in FY2024 (-24.1%), 11.96 in FY2023 (-5.2%), 12.62 in FY2022 (+32.2%) and 9.54 in FY2021 (+45.5%).
- The Q2 2026 figure marks the highest quarterly EV to CFO in data going back to Q2 2015.
- Compared with a year earlier, EV to CFO was higher in three of the last seven quarters, with growth averaging 141.5%.
- The best year-over-year quarter for EV to CFO over five years was Q4 2025 (growth of 492.4%); the worst was Q2 2024 (a decline of 64.8%).
- Per Business Quant data, SUPN's EV to CFO in the three quarters before Q2 2026 was 31.42 (Q1 2026), 53.81 (Q4 2025) and 34.07 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Supernus Pharmaceuticals | 2.39 Bn | 1.04 Bn | 185.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 117.18 |
| Mar 31, 2026 | 31.42 |
| Dec 31, 2025 | 53.81 |
| Sep 30, 2025 | 34.07 |
| Jun 30, 2025 | 6.66 |
| Mar 31, 2025 | 8.35 |
| Dec 31, 2024 | 9.08 |
| Sep 30, 2024 | 7.64 |
| Jun 30, 2024 | 7.27 |
| Mar 31, 2024 | 15.63 |
| Dec 31, 2023 | 11.96 |
| Sep 30, 2023 | 13.83 |
| Jun 30, 2023 | 20.64 |
| Mar 31, 2023 | 10.75 |
| Dec 31, 2022 | 12.62 |
| Sep 30, 2022 | 10.22 |
| Jun 30, 2022 | 9.82 |
| Mar 31, 2022 | 14.80 |
| Dec 31, 2021 | 9.54 |
| Sep 30, 2021 | 8.76 |
API Access
Supernus Pharmaceuticals EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();